Literature DB >> 22236862

Ethionamide-induced hypothyroidism.

Bikram S Dutta, G Hassan, Q Waseem, S Saheer, Abhijeet Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22236862     DOI： 10.5588/ijtld.11.0388

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  8 in total

1.  Ethionamide: Unusual Cause of Hypothyroidism.

Authors:  Ajay Raj Mallela; Rohini Koya; Shivashankara Kaniyoor Nagari; Aswini Kumar Mohapatra
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 3.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

4.  Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa.

Authors:  James C M Brust; N Sarita Shah; Theo L van der Merwe; Sheila Bamber; Yuming Ning; Moonseong Heo; Anthony P Moll; Marian Loveday; Umesh G Lalloo; Gerald H Friedland; Neel R Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

5.  The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study.

Authors:  Wanli Kang; Jian Du; Song Yang; Jiajia Yu; Hongyan Chen; Jianxiong Liu; Jinshan Ma; Mingwu Li; Jingmin Qin; Wei Shu; Peilan Zong; Yi Zhang; Yongkang Dong; Zhiyi Yang; Zaoxian Mei; Qunyi Deng; Pu Wang; Wenge Han; Meiying Wu; Ling Chen; Xinguo Zhao; Lei Tan; Fujian Li; Chao Zheng; Hongwei Liu; Xinjie Li; A Ertai; Yingrong Du; Fenglin Liu; Wenyu Cui; Quanhong Wang; Xiaohong Chen; Junfeng Han; Qingyao Xie; Yanmei Feng; Wenyu Liu; Peijun Tang; Jianyong Zhang; Jian Zheng; Dawei Chen; Xiangyang Yao; Tong Ren; Yang Li; Yuanyuan Li; Lei Wu; Qiang Song; Mei Yang; Jian Zhang; Yuanyuan Liu; Shuliang Guo; Kun Yan; Xinghua Shen; Dan Lei; Yangli Zhang; Xiaofeng Yan; Liang Li; Shenjie Tang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-22       Impact factor: 3.267

6.  The function of the thyroid gland in patients with multi-drug resistant tuberculosis.

Authors:  S L Matveyeva; O S Shevchenko; O O Pogorelova
Journal:  Antimicrob Resist Infect Control       Date:  2017-08-16       Impact factor: 4.887

Review 7.  MDR Tuberculosis Treatment.

Authors:  Juan Espinosa-Pereiro; Adrian Sánchez-Montalvá; Maria Luisa Aznar; Maria Espiau
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

8.  High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.

Authors:  Aristomo Andries; Petros Isaakidis; Mrinalini Das; Samsuddin Khan; Roma Paryani; Chitranjan Desai; Alpa Dalal; Homa Mansoor; Reena Verma; Dolorosa Fernandes; Giovanni Sotgiu; Giovanni B Migliori; Peter Saranchuk
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.